Trading Summary - November 24. Initial undercut ask and

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
151
Trading Summary - November 24.

Initial undercut ask and hold back attempt at .0004 taken out with 1.5M buy order.

1 x 5000 share ineffective paint down attempt - double printed - continued to partially fill one of the large long-standing whale bids.

No change at .0005 - 41M which included partially suspect amount of 29M from NITE.

7M undercut ask put up at .0004 late in the day - that will probably get taken out by one or more of the long-term whales if left there on the PR day.

The whale bid at .0003 remained at 77M all day.

Only 18M has been picked up on the bid at .0003 in 14 weeks - all of it from insignificant paint downs in conjunction with associated bashing comments on iHub from the usual suspects operating in a conspiracy by repeating nonsense to each other which they try to portray as fact.

The PR associated with the Q3 - that was filed on November 16 - has not been issued yet. Look out for it every day next week.

There is still a lot of activity going on at present for traders elsewhere with a major long-term mover reaching new highs daily. That stock will be the main topic of conversation over the weekend although it is not in the same price range as $DIGX. $DIGX will appeal more to the savvy off-the-bottom watchers / alerters depending on the timing of any PR and whether they have got into other positions or not at the time of release..

In addition, savvy traders are still loading some of the beaten down stocks which will benefit from the SEC ordered cancellation of aged debt stocks and conversion rights held by scammers. Many of the stocks involved I recognise as having had bashers on the iHub "usual suspects" list involved in a conspiracy to affect the price of those stocks in the past.

Until the PR comes out highlighting the excellent results - and hopefully also updating future brand expansion plans - only those who were looking for the Q3 - who mostly already have their shares - have seen it.

Stay sharp if you don't already have all the shares you need to make your profit expectations in 2017 and up to Q4 in March 2018. Prior warning and / or scanner alerts of any significant buys when the PR comes out will not be given on iHub.

The long-term whales who trade $DIGX will continue to buy shares at any price that makes sense to them to use on multiple runs during the remainder of 2017 (there is usually a Q4 estimate + plans update in December) and throughout 2018.

Content below the line mainly unchanged from last update - relevant to those that are new here.


As previously stated, the large additional share retirement of 275M shares since Jul 31 - on top of the 150M retired Dec 2016 > May 2017 making 425M total - has not been PR'ed yet either.

For 14 weeks now, nobody has been duped by the fake stacked ask at .0005 or the nonsense from the non-credible bashers on iHub to sell any significant amount for a loss at .0003.

Excellent update recently on the Verified Company Profile share structure at otcmarkets.com from the Transfer Agent (see new sticky #1902) - this has not been PR'ed yet to the wider investing community and has not been spotted by the inattentive on iHub:

O/S and A/S confirmed unchanged.

Float same as for all the runs this year - 50M reduction since Dec 2016.

Another 275M shares retired between Jul 31 and Oct 31 (as promised).

That takes total retired to 425M since May 31 - a significant reduction on such a small A/S and O/S for a stock in this price range.

There are at least 4 x whales who trade $DIGX continuously throughout each year who will be happy to take around 20M each if anyone is stupid or impatient enough to sell for a loss at any level below the current one. Any shares bought at .0004 will be worth an easy 150%+ profit on any of numerous runs likely to happen through to Q3 and Q4. Shares bought at .0005 should easily return 100%+ at some point in 2017 or 2018.

In my experience, 70M>100M is the optimum amount to take best advantage of each run whilst keeping the 25M cheapest batches for the bigger runs next year (especially Q4 in March 2018 when the full year profits will be up). My cheapest 25M retained for next year will not require any shares bought above .0004 now so all others will be tradeable for up to 100% during the remaining runs in 2017.

As expected, the status quo has been maintained throughout the inter Q2/Q3 PR period with it making little difference to long-term traders whether shares are picked up at .0004/5/6 - they will see a profit on all of them by Q3 / Q4 and on various runs between. The big boys in DIGX will probably be aiming to have an inventory of 50M>120M for trading through to end-2017 and in 2018.

Also expect further elements of the .0003 bidders - particularly those unlikely to fill on paint downs in the time remaining before the next run prior to / at Q3 - to continue to buy .0004s and .0005s whilst they are still available until they meet their desired holding. Only 50% of the bid at .0003 hitting the ask at .0005 would be sufficient to take out even the current fake ask if left there.

We can now look forward to additional updates on both the possible merger discussed recently and the implementation of the additional services being offered in the chiropractic chain offices - per the Strategic Growth Plan announced earlier - over the coming days, weeks and months..

The long whales will continue to buy at all prices that makes sense to them at any given point to have a cache for trading on any demand led run, the Q3 and through to the Annual Report in March 2018.

$DIGX will most likely not be allowed to go to previous year-end or inter-Q lows.

In my opinion, nobody has bought $DIGX in 2017 at a price that it isn't likely to exceed in the coming months (2017 high .0013) through to the Annual Report (March 2018).

Ludicrous claims by the notorious bashers currently on iHub - "RFB", "munimi", "Crown Capital" and "surfkast" - are clearly seen as such by all serious traders and now even by most short term (next Q) iHubbers.

Debunking nonsense posted by morons on iHub, there is absolutely no need or intention to do a reverse split. The share structure is exceptionally thin - with no dilution - and the company has been buying back shares. OTC market specialists who trade $DIGX continuously would not be loading 50M>120M shares at these inter-Q bottom prices to trade over the next 6 months if there was even the remote possibility of a reverse split.

Regardless of whether iHub posters lose interest over the coming days and weeks, detailed coverage will continue here as $DIGX remains one of my top picks for repeat profits for those that are patient and trade it to best effect (keep all cheapest batches of shares - create an inventory of shares at higher prices to trade on every run - big or small).

In addition, money is not considered "dead" by the most successful traders in the OTC market when they know it will provide a significant return further down the line because they are in a position to understand and influence - through keen observation and record keeping - what volume of shares is likely to be made available for purchase at any particular level.








American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PPL Reports Strong Q3; Long-Term EPS Growth Up

Updated Category News Views 29

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

Continue Reading
Thryfter Unleashes Livestream Magic at Goodwill Event

Updated Category News Views 89

A Dynamic Shift in Thrift Shopping All eyes might be on Thryfter this November as they drop some serious retail knowledge at the Goodwill CONNECT Conference in Houston. We’re talking about a tech shake-up for Goodwill’s model, thanks to Thryfter's livestream shopping craze that’s poised to weld traditional thrifting with digital reach. The Power of Virtual Thrift...

Continue Reading
RCMA Makeup Makes Bold Retail Move with Ulta.com Debut

Updated Category News Views 25

RCMA Makeup: A Longstanding Industry Insider You know when a brand’s been around the block since the 60s, it’s got staying power. RCMA Makeup’s been a snug fit in the toolbox of professional makeup artists for over six decades. This ain't some fly-by-night operation. They’ve thrived on word of mouth—no flashy ads or promotional stunts. Just rock-solid reputation...

Continue Reading
Encompass Health Faces Uncertain Future with Sea Pines

Updated Category News Views 68

Unexpected Downpour Closes Sea Pines They say when it rains, it pours. That's not just true in life, but as it happens, it's quite literal in Melbourne, Florida. A deluge of biblical proportions forced an immediate lockdown of the Sea Pines Rehabilitation Hospital. Flooded to the gills, this once stalwart institution finds its doors shuttered indefinitely. It's a...

Continue Reading
Home Insurance Depreciation and What it Means for You

Updated Category News Views 17

A Deep Dive into Depreciation's Impact on Home Insurance Folks, if you haven't battled the insurance beast, you're missing out on an unholy mess. Let's talk about something that's been quietly gnawing at homeowners’ wallets—depreciation in home insurance claims. Peggy Schneider, an insurance guru from Kalispell, Montana, lays it all out in HelloNation, and I'm here to...

Continue Reading
CMS 2027 Fee Schedule: Game Changer for SI Joint Procedures

Updated Category News Views 145

CMS's Move: A New Payment Pathway You don't expect bureaucrats to stir things up, but check this out: the CMS 2027 Physician Fee Schedule has done just that by setting a non-facility (office) payment rate for CPT code 27279. This code covers those fiddly, minimally invasive sacroiliac (SI) joint procedures, where you engage bone and get down to real orthopedic business....

Continue Reading
Koozee Boosts Apparel Design with AI Workflows

Updated Category News Views 108

Revolutionizing Apparel Design with AI If you've ever wondered how tech can make an impact on the fashion world, Koozee's latest update provides an eye-opening look. This isn't about following trends—it's about setting them, and Koozee’s making a bold move with its newest platform enhancements. Introducing Freeform Canvas Koozee has launched the Freeform Canvas, a...

Continue Reading
Strategies for Maintaining Water Quality in NH Homes

Updated Category News Views 92

Protect Your Water: Steps to Safe Drinking Imagine turning on your kitchen tap, and instead of refreshing, clean water, you get a murky mystery. Not exactly anyone's dream scenario, right? Enter Sean McGorry and his down-to-earth guide to water quality for New Hampshire homesteaders. It's not rocket science, but the whispers of neglected water systems tell tales of...

Continue Reading
Upright Proton Therapy: New Era for Cancer Care

Updated Category News Views 129

BayCare's Bold Step into Upright Proton Therapy Here's a twist for you—BayCare Health System has rolled out something that's genuinely pushing the envelope in cancer treatment. They've treated their first patient with an upright proton therapy system. Now, talk about innovation that shakes things up. This isn't just any old upgrade; it's a complete revamp of how proton...

Continue Reading
SM Investments Wins Five Golden Arrows: Governance on Point

Updated Category News Views 82

Gold Arrows and Golden Standards What’s in a bunch of gold arrows, you might ask? Well, for SM Investments Corporation, those Five Golden Arrows from the Institute of Corporate Directors aren't just shiny trinkets. They're badges of honor, symbols of a rock-solid governance fortress. For the third year running, they’ve nailed the top spot under the corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Yale School of Medicine Celebrates Achievements in Research

Updated Category News Views 167

Yale School of Medicine Celebrates Achievements in Research Today, twenty-seven distinguished faculty members from Yale School of Medicine (YSM) were honored for their remarkable contributions to the field of medical research. Recognized as Highly Cited Researchers for the year 2025, these experts are acknowledged for their influential studies that have garnered...

Continue Reading
Saothair Capital Partners Strengthens Portfolio with T BAILEY

Updated Category News Views 399

Saothair Capital Partners Acquires Majority Stake in T BAILEY In a strategic move, Saothair Capital Partners, LLC has completed the acquisition of a majority equity stake in T BAILEY, LLC. This acquisition signals Saothair's commitment to investing in the middle-market manufacturing sector. Known for its extensive experience and focus, Saothair aims to enhance T BAILEY's...

Continue Reading
Semtech's Earnings Report: What to Anticipate This Quarter

Updated Category News Views 114

Semtech's Earnings Report: What Investors Should Expect Semtech (NASDAQ: SMTC) is gearing up to release its latest quarterly earnings report shortly. As anticipation builds, it's crucial for investors to stay informed on what this means for their holdings in the company. Analysts have projected that Semtech will deliver an earnings per share (EPS) of $0.23. Investors are...

Continue Reading
Vistra Energy Faces Challenges After Battery Facility Fire

Updated Category News Views 192

Vistra Energy Stock Takes a Hit Due to Facility Incident Shares of Vistra Energy (NYSE: VST) experienced a decline of 1.4% in early trading today, following reports of a significant fire at a battery facility located at the company’s Moss Landing power plant. This facility, situated in Monterey County, was put into emergency lockdown as authorities evacuated surrounding...

Continue Reading
Compass Therapeutics Elevates Growth with $120 Million Offering

Updated Category News Views 186

Compass Therapeutics Unveils Significant Public Offering Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a dedicated clinical-stage biopharmaceutical company focused on oncology, has excitedly announced the pricing of an upsized public offering. This offering includes 33,290,000 shares of common stock priced at $3.00 each, along with pre-funded warrants for...

Continue Reading